STERIALS

A clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma delta T cell therapies for the treatment of cancer based on human efficacy data in acute myeloid leukemia, and advancing the development of safer and more affordable CAR-T products that effectively identify and target both liquid and solid tumors, as well as developing gamma delta T cell therapies for the treatment of infectious diseases.